All Articles

Servier's new trial for a fatal pediatric epilepsy is more than a medical milestone; it's a strategic bet on high-risk, high-reward rare disease markets.

Lycia Therapeutics' oversubscribed $75M Series D validates its unique LYTAC platform, which aims to treat autoimmune diseases by destroying harmful proteins.

An institutional investor just paid a 25% premium for VCI Global stock. We go beyond the headline to unpack the AI platform that commanded this confidence.

RenX Enterprises pushes forward with its advanced soil facility, but a key mill is delayed, highlighting the clash between green-tech vision and reality.

Koppers reports historic safety and emissions lows in its 2025 CSR, but the real story is its refreshed 2030 strategy—a plan for resilience and value.

As the GLP-1 market booms, Vivani Medical's new semaglutide implant promises a 'set-and-forget' solution to the adherence crisis plaguing weight-loss drugs.

Automotive tech giant Visteon announced a massive share repurchase, delighting Wall Street. But in an industry demanding relentless innovation, is this the best use of capital?

Bluespring Wealth's acquisition of Element Wealth Advisors highlights a key industry trend: indie firms are seeking scale and tech to fuel client-first growth.

A new partnership promises a less painful way to deliver cancer immunotherapy. We dive into the tech, the market, and why this is a key strategic play.

Facing a silent crisis in its vast underwater prairies, Indonesia is pioneering a new collaborative framework to unify fragmented data and save its vital seagrass.

ePLDT's new alliance with Vantiq aims to move Philippine AI from theory to real-time action, bolstering digital sovereignty and reshaping the national tech landscape.

Freedom Holding Corp. secured a key S&P upgrade for its subsidiaries, bolstering its aggressive global expansion. But can its risk controls keep pace?

A stunning 12GWh in deals from a single event signals more than a company win; it reveals the new rules of the global energy storage race. Here's why.

NuCube Energy is going public via a $500M SPAC deal to fund its microreactors. Can this high-stakes bet deliver clean power to data centers and industry?

A £1.3M debt dispute escalates as the National Bank of Uzbekistan pursues Solfy CA in English courts, alleging a smear campaign to derail justice.

Hyundai secures top JD Power rankings by focusing on fundamentals, a stark contrast to an industry where improving quality is undermined by tech frustrations.

Summer trip costs are soaring to nearly $10,000, yet travelers are buying less insurance. We uncover the five critical errors that could cost you everything.

Professor Jason Chin’s Heinrich Wieland Prize signals a new era. His work in synthetic biology is enabling Constructive Bio to forge a new class of drugs.

At Intersolar 2026, Astronergy unveiled its ASTRO N7s 3.0. Beyond the efficiency gains, the real story is how it redefines the residential solar market.